Nightly News   |  August 28, 2014

FDA investigating Singulair suicide risk

March 27: A top-selling asthma drug is being probed for possible links to suicidal behavior after thousands have complained of behavior changes while on the medication. NBC Chief Medical Correspondent Robert Bazell reports.

Share This:

Sorry, we do not have a transcript available for this video at this time.